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    Many proteins perform their physiological functions by adopting their unique three-
dimensional structures, and failure to achieve such native structures often leads to fatal diseases.  
Cu/Zn-superoxide dismutase (SOD1) has essential roles in removing toxic superoxide radicals, 
and mutations in SOD1 gene cause familial forms of amyotrophic lateral sclerosis (SOD1-ALS).  
In SOD1-ALS, mutant SOD1 abnormally accumulates in affected motoneurons as “mis”-folded 
forms such as aggregates and oligomers.  Despite this, it remains obscure how ALS-causing 
mutations lead to the misfolding of SOD1.  In my thesis, I have focused on a highly-conserved 
disulfide bond in SOD1 and proposed a misfolding mechanism in which mutant SOD1 shuffles 
the disulfide to form disulfide-crosslinked oligomers (S-S oligomers). 
    Chapter 1 is a general introduction describing the previous studies on the structure and 
function of SOD1 as well as the misfolding of SOD1 in ALS.  Also, the purpose of the research 
in my thesis is mentioned. 
    Chapter 2 summarizes the methods of protein preparation and also the basic experimental 
techniques performed in this thesis. 
    In chapter 3, I will report the mechanism of disulfide shuffling in mutant SOD1 in vitro and 
also describe several compounds that can efficiently suppress the formation of S-S oligomers.  
The mechanism is further proposed on how those compounds inhibit the formation of S-S 
oligomers, and the potential of those compounds as cures for ALS is also discussed. 
    In chapter 4, the formation mechanism of S-S oligomers will be characterized in more detail 
by using calorimetry, various spectroscopic methods, and small angle X-ray scattering.  At 
physiological temperature, mutant SOD1 was found to adopt a compact dimeric configuration 
with no secondary structures.  Exposure of cysteine residues in such misfolded conformations 
have important roles in allowing the disulfide bond to be shuffled. 
    In chapter 5, roles of S-S oligomers in the pathology of SOD1-ALS are discussed.  I have 
also discussed pathological involvement of aberrant S-S shuffling in the other human diseases 
with protein aggregation and oligomerization. 
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